31 reports of this reaction
4.6% of all BENZOCAINE AND MENTHOL reports
#1 most reported adverse reaction
DYSPNOEA is the #1 most commonly reported adverse reaction for BENZOCAINE AND MENTHOL, manufactured by RB Health (US) LLC. There are 31 FDA adverse event reports linking BENZOCAINE AND MENTHOL to DYSPNOEA. This represents approximately 4.6% of all 672 adverse event reports for this drug.
Patients taking BENZOCAINE AND MENTHOL who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DYSPNOEA is moderately reported among BENZOCAINE AND MENTHOL users, representing a notable but not dominant share of adverse events.
In addition to dyspnoea, the following adverse reactions have been reported for BENZOCAINE AND MENTHOL:
The following drugs have also been linked to dyspnoea in FDA adverse event reports:
DYSPNOEA has been reported as an adverse event in 31 FDA reports for BENZOCAINE AND MENTHOL. This does not prove causation, but indicates an association observed in post-market surveillance data.
DYSPNOEA accounts for approximately 4.6% of all adverse event reports for BENZOCAINE AND MENTHOL, making it one of the most commonly reported side effect.
If you experience dyspnoea while taking BENZOCAINE AND MENTHOL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.